✦ LIBER ✦

Anti-EGFR (cetuximab) combined with irinotecan for treatment of elderly patients with metastatic colorectal cancer (mCRC)

✍ Scribed by S. Abdelwahab, A. Azmy, H. Abdel-aziz, H. Salim, A. Mahmoud

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EGFR ligands as pharmacodynamic biomarke

✍ Fotios Loupakis, Chiara Cremolini, Anna Fioravanti, Paola Orlandi… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 320 KB

Cetuximab combined to chemotherapy in el

✍ Boudabous, H.; Belhabib, G.; Lariviere, I.; Ahmed, S.; Chouchene, N.; Boussen, H 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 46 KB

6119 Triple mutational testing for respo

✍ Spindler, K.; Pallisgaard, N.; Lindebjerg, J.A.N.; Jakobsen, A. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Retrospective analysis of cetuximab mono

✍ Ayako Mizota; Kohei Shitara; Chihiro Kondo; Motoo Nomura; Tomoya Yokota; Daisuke 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 202 KB

PCN17 THE COST-EFFECTIVENESS OF CETUXIMA

✍ D Tilden; D Thurley; J White; M Aristides 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

664 PUBLICATION Cetuximab in combination

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 137 KB